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PS190.
The Role of Magnetic Resonance Imaging and a Func-
tional Classification Scheme in the Diagnosis and Man-
agement of Patients with Vascular Malformations
Michael Lidsky, Charles Spritzer, Cynthia Shortell. Duke
University, Durham, NC
Objectives: Vascular malformations (VM) are rare
but confer significant morbidity. Limitations in diagno-
sis and treatment result from inadequate classification
schema and diagnostic algorithms. The crucial distinc-
tion is between high flow and low flow lesions, as this
informs both prognosis and treatment. This study is
designed to assess the utility of dynamic contrast en-
hanced magnetic resonance imaging (dceMRI) in distin-
guishing high flow from low flow lesions utilizing the
proposed classification scheme.
Methods: A prospective database of all patients re-
ferred to the multidisciplinary Vascular Malformation
team at our institution was reviewed from January 2008
to June 2010. dceMRI was obtained on each patient to
determine flow characteristics and lesion extent. Addi-
tional studies were utilized as indicated. Catheter-based
arteriography was performed when high flow lesions
were identified with the intention of intervening, or to
distinguish between high and low flow lesions whenMRI
was indeterminate. A classification scheme was used to
evaluate patients and formulate diagnostic and therapeu-
tic goals. We analyzed the accuracy of various diagnostic
modalities in identifying high and low flow lesions.
Results: The 122 patients included 52 males (42.6%)
and 70 (57.4%) females. Pain (72 patients; 59%) and swell-
ing (88 patients; 72.1%) were themost common presenting
symptoms. Diagnostic modalities employed were dceMRI
(122 patients; 100%), catheter-based arteriography (18
patients; 14.8%), ultrasound (17 patients; 13.9%), and
computed tomography (8 patients; 6.6%). dceMRI was
diagnostic in 109 of 122 studies performed (89.3% accu-
racy), with only 13 arteriograms conducted to confirm
indeterminate dceMRI findings.
Conclusions: Using a classification scheme designed
to identify key clinical characteristics, we were able to
successfully distinguish between high flow and low flow
VMs utilizing dceMRI alone in 89% of patients, minimiz-
ing the need for unnecessary invasive catheter-based
procedures.
Author Disclosures: M. Lidsky: Nothing to disclose; C.
Shortell: Nothing to disclose; C. Spritzer: Nothing to
disclose.S192.
ortoiliac Thrombus Complicating Inflammatory
owel Disease
uldeep Singh, Jonathan Deitch, Ming Li Wang. Vascular
urgery, Staten Island University Hospital, Staten island,
Y
Objectives: Arterial thrombi complicating Inflamma-
ory bowel disease (IBD) occurs very rarely. We present a
ase of a patient with Crohn’s disease who was found to
ave an isolated aortoiliac thrombus.
Methods: A 28-year- old male with Crohn’s disease
resented with bilateral leg pain and abdominal pain. A
T scan revealed a saddle embolus at the aortic bifurca-
ion, aortoiliac thromboembolectomies were performed
ith successful restoration blood flow. Long-term anti-
oagulation was instituted following a negative hyperco-
gulable workup. He was discharged with no further
omplaints relating to the thrombus.
Results: After an English review of literature (Table
) we found only 16 reported cases of isolated aortic
hrombus in IBD. Studies have shown thrombosis in
BD is not related to prothrombotic states but appears to
e secondary to a prothrombotic stimulus from systemic
nflammation.
Conclusions: Arterial thrombosis is a serious compli-
ation of IBD with mortality rates reported from 8-25%.
he most important risk factor for thrombosis is disease
everity as reported in literature. Treating physicians
hould be aware of an increased thromboembolic risk in
BD and have a heightened awareness of possible arterial
hrombotic events.
nglish litrature review of aortic thombi complicating
nflammatory bowel disease
uthor Patient IBD Coagulopathy Treatment Outcome
Thrombus
location
ovotny 35F 22F
34F
UC UC
UC
NA NA NA NA NA T,
AC
Leg Amputation
Good Good
Ab Aorta
Ab
Aorta
Ab
Aorta
ehman 50F CD Anticardio
antibody
AC Good Ab Aorta
albot 47M CD NA None Death Ab Aorta
erler 34F CD Normal T/A, AC Good Ab. Aorta
ovacek 36F 41F UC CD Normal
Normal
AC E, AC Good Leg amp Ab Aorta
Ab
Aorta
ahn 34F 74F CD CD Normal NA E, AC AC Good Toe amp Ab Aorta
Ab
Aorta
zychta 42F UC Low AT T, E, AC Death Ab Aorta
rothues 49M UC Low AT NA Death Aortic
arch
han 41M CD NA NA Death thoracic
Aorta
lder 63M UC Normal T, AC Good Aortic
arch,
Ab
Aorta
ok 48F UC Normal AC Good Thoracic
Aorta
iFabio 62F UC NA AC and
Surgery
Good Ab Aorta
resent
Case 28M CD Normal T,E,AC Good Ab Aorta
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PS194.
Role of Erythropoietin Receptors and Ligands in At-
tenuating Inflammation and Apoptosis in Critical
Limb Ischemia
Dhiraj Joshi, Janice Tsui, Hemanshu Patel, Xu Shiwen,
George Hamilton, David Abraham, Daryll Baker. Royal
Free Hospital, London, United Kingdom
Objectives: Erythropoietin (EPO) exerts tissue-pro-
tective effect through a hetero-receptor complex (EPOR-
CD131). The aims of this study were to: 1. Examine the
expression of EPOR-CD131 in skeletal muscle obtained
from human critical limb ischaemia (CLI) compared with
control muscle; and 2. Investigate the tissue protective
effects of EPO and a non-haematopoietic helix-B peptide
of EPO (ARA 290) in an in vitro model of skeletal myotube
ischemia.
Methods: Tissue samples were obtained from the
gastrocnemius muscle of patients undergoing peri-
genicular lower extremity amputation for CLI (n12).
Control samples were obtained from patients undergo-
ing cardiac surgery (n12). Immunohistochemistry and
western blot were used to demonstrate the expression of
EPOR-CD131.
An in vitro model system of skeletal myotube isch-
emia was created using C2C12 myotubes in hypoxic
chambers. Myotubes were pre-treated with EPO or ARA
290 before exposure to simulated ischemia. Inflamma-
tory cytokines were measured using ELISA. Apoptosis
and cell death were determined by cleaved caspase-3
assay and lactate dehydrogenase (LDH) release
respectively.
Results: There was an expression of EPOR and
CD131 in both ischemic and normal skeletal muscle cells
with co-localization of EPOR-CD131. The expression
of receptors was upregulated in CLI (p0.01). EPO and
ARA 290 attenuated the release of Interleukin-6, and
reduced the cleaved caspase-3 and the release of LDH
from the myotubes exposed to simulated ischemia
(p0.01).
Conclusions: Here we report the first study demon-
strating expression of EPO receptors within skeletal muscle
cells and elevated expression in CLI. We also show that
EPO, and the non-haematopoietic helix-B peptide of EPO
(ARA 290), decreases inflammation and apoptosis of isch-
emic myotubes in vitro. Our data suggests that the use of
EPO derivatives (ARA 290) to selectively enhance the
tissue protective activity of EPO may provide a novel ther-
apeutic avenue for CLI.
Author Disclosures: D. Abraham: Nothing to disclose;
D. Baker: Nothing to disclose; G. Hamilton: Nothing toisclose; D. Joshi: Nothing to disclose; H. Patel: Nothing
o disclose; X. Shiwen: Nothing to disclose; J. Tsui:
othing to disclose.
S196.
itochondrial Heat Shock Proteins Regulate Vascular
mooth Muscle Cell Responses to Oxidant Stress and
etermine Apoptotic Threshold
hanh P. Nguyen, Hope Lancero, Sara J. Runge, Andrey
ymar, Michael S. Conte. Surgery, UCSF, San Francisco,
A
Objectives: Resistance to apoptosis is a salient feature
f neoplasia and neointimal hyperplasia. In cancer cells, a
itochondrial chaperone network consisting of Hsp-90
nd its congener Hsp-75 maintains mitochondrial mem-
rane integrity and mediates apoptosis-resistance. We hy-
othesize that an analogous network regulates survival in
SMC.
Methods: VSMC from human saphenous vein were
reated with: growth factor (PDGF-BB), cytokine (TNF),
tatins, siRNA (Hsp-75 vs non-targeting), or recombinant
denovirus(Ad-GFP control vs Ad-Hsp75). Real-time PCR
nd western blotting (total cell lysates and mitochondrial
ub-fractions) were performed. Apoptosis was quantified
y DNA content cytometry and Annexin V. Mitochondrial
embrane potential (MMP) was measured after an oxida-
ive challenge with peroxynitrite (0-1000 uM).
Results: PDGF-BB and TNF induced upregulation
f Hsp-90, Hsp-75, and their anti-apoptotic client protein
urvivin (SVV) within mitochondria. Pretreatment with
hese agonists resulted in MMP hyperpolarization and pro-
